DK2809669T3 - Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika - Google Patents
Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika Download PDFInfo
- Publication number
- DK2809669T3 DK2809669T3 DK13702225.7T DK13702225T DK2809669T3 DK 2809669 T3 DK2809669 T3 DK 2809669T3 DK 13702225 T DK13702225 T DK 13702225T DK 2809669 T3 DK2809669 T3 DK 2809669T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrroldicarboxamides
- pharmaceuticals
- condensed
- condensed pyrroldicarboxamides
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305129 | 2012-02-03 | ||
| PCT/EP2013/051996 WO2013113860A1 (en) | 2012-02-03 | 2013-02-01 | Fused pyrroledicarboxamides and their use as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2809669T3 true DK2809669T3 (da) | 2017-05-01 |
Family
ID=47631438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13702225.7T DK2809669T3 (da) | 2012-02-03 | 2013-02-01 | Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US9284333B2 (da) |
| EP (1) | EP2809669B1 (da) |
| JP (1) | JP6126135B2 (da) |
| KR (1) | KR102017362B1 (da) |
| CN (1) | CN104169281B (da) |
| AR (1) | AR089863A1 (da) |
| AU (1) | AU2013214226B2 (da) |
| BR (1) | BR112014018767B1 (da) |
| CA (1) | CA2860933C (da) |
| CY (1) | CY1119108T1 (da) |
| DK (1) | DK2809669T3 (da) |
| ES (1) | ES2623167T3 (da) |
| HR (1) | HRP20170618T1 (da) |
| HU (1) | HUE031729T2 (da) |
| LT (1) | LT2809669T (da) |
| MX (1) | MX350793B (da) |
| PL (1) | PL2809669T3 (da) |
| PT (1) | PT2809669T (da) |
| RU (1) | RU2650111C2 (da) |
| SG (1) | SG11201403852UA (da) |
| SI (1) | SI2809669T1 (da) |
| UY (1) | UY34610A (da) |
| WO (1) | WO2013113860A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017097671A1 (de) * | 2015-12-10 | 2017-06-15 | Bayer Pharma Aktiengesellschaft | Substituierte perhydropyrrolo[3,4-c]pyrrol-derivate und ihre verwendung |
| KR20180088462A (ko) | 2015-12-10 | 2018-08-03 | 바이엘 파마 악티엔게젤샤프트 | 수면-관련 호흡기 장애의 치료를 위한 TASK-1 및 TASK-2 채널의 차단제로서의 2-페닐-3-(피페라지노메틸)이미다조[1,2-a]피리딘 유도체 |
| WO2017110881A1 (ja) | 2015-12-25 | 2017-06-29 | 武田薬品工業株式会社 | 医薬 |
| EP3437644B1 (en) | 2016-03-28 | 2021-06-30 | Takeda Pharmaceutical Company Limited | Compounds for use in the treatment of pulmonary hypertension |
| JOP20190005A1 (ar) * | 2016-07-20 | 2019-01-20 | Bayer Ag | مركبات ديازاهيترو ثنائية الحلقة مستبدلة واستخداماتها |
| US11844605B2 (en) | 2016-11-10 | 2023-12-19 | The Research Foundation For Suny | System, method and biomarkers for airway obstruction |
| US10919891B2 (en) * | 2017-04-27 | 2021-02-16 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JOP20190284A1 (ar) | 2017-06-14 | 2019-12-11 | Bayer Pharma AG | مركبات إيميدازوبيريميدين مستبدلة بديازا ثنائي الحلقة واستخدامها للمعالجة من اضطرابات التنفس |
| EP3836918A1 (en) | 2018-08-15 | 2021-06-23 | Universität Heidelberg | Task-1 inhibitors for treatment of atrial arrhythmias |
| CA3207590A1 (en) * | 2021-02-08 | 2022-08-11 | Xuejun Zhang | Pyridopyrimidinone derivative, preparation method therefor, and use thereof |
| WO2023225177A1 (en) * | 2022-05-19 | 2023-11-23 | Enalare Therapeutics Inc. | Methods and pharmaceutical compositions to treat respiratory depression in patients |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU83327A1 (fr) | 1981-04-29 | 1983-03-24 | Midit | Procede de preparation de derives de 1,4-thiazine,leur utilisation ainsi que compositions contenant ces derives |
| EP0447704A1 (en) | 1990-03-21 | 1991-09-25 | Smithkline Beecham Farmaceutici S.p.A. | N-Acylated azacyclic compounds, processes for their preparations and their use as medications |
| US7030112B2 (en) | 2003-03-25 | 2006-04-18 | Bristol-Myers Squibb Company | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| DE10332685A1 (de) | 2003-07-18 | 2005-02-17 | Bayer Healthcare Ag | Vorhof-selektiv exprimierte Kaliumkanäle |
| DE102005028862A1 (de) * | 2005-06-22 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| CN101636154B (zh) | 2006-04-27 | 2011-12-14 | 塞诺菲-安万特德国有限公司 | Task-1和task-3离子通道抑制剂 |
| WO2008053319A1 (en) | 2006-10-30 | 2008-05-08 | Pfizer Products Inc. | Amide resorcinol compounds |
| NZ582871A (en) * | 2007-07-27 | 2011-09-30 | Sanofi Aventis | 1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5- tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
-
2013
- 2013-02-01 CA CA2860933A patent/CA2860933C/en active Active
- 2013-02-01 AR ARP130100297A patent/AR089863A1/es unknown
- 2013-02-01 MX MX2014009356A patent/MX350793B/es active IP Right Grant
- 2013-02-01 KR KR1020147024134A patent/KR102017362B1/ko active IP Right Grant
- 2013-02-01 PL PL13702225T patent/PL2809669T3/pl unknown
- 2013-02-01 LT LTEP13702225.7T patent/LT2809669T/lt unknown
- 2013-02-01 SI SI201330622A patent/SI2809669T1/sl unknown
- 2013-02-01 PT PT137022257T patent/PT2809669T/pt unknown
- 2013-02-01 WO PCT/EP2013/051996 patent/WO2013113860A1/en active Application Filing
- 2013-02-01 EP EP13702225.7A patent/EP2809669B1/en active Active
- 2013-02-01 BR BR112014018767-3A patent/BR112014018767B1/pt active IP Right Grant
- 2013-02-01 RU RU2014135759A patent/RU2650111C2/ru active
- 2013-02-01 US US14/375,273 patent/US9284333B2/en active Active
- 2013-02-01 HU HUE13702225A patent/HUE031729T2/en unknown
- 2013-02-01 DK DK13702225.7T patent/DK2809669T3/da active
- 2013-02-01 UY UY0001034610A patent/UY34610A/es not_active Application Discontinuation
- 2013-02-01 ES ES13702225T patent/ES2623167T3/es active Active
- 2013-02-01 AU AU2013214226A patent/AU2013214226B2/en active Active
- 2013-02-01 JP JP2014555214A patent/JP6126135B2/ja active Active
- 2013-02-01 CN CN201380007669.7A patent/CN104169281B/zh active Active
- 2013-02-01 SG SG11201403852UA patent/SG11201403852UA/en unknown
-
2016
- 2016-02-11 US US15/041,541 patent/US9884860B2/en active Active
-
2017
- 2017-04-19 HR HRP20170618TT patent/HRP20170618T1/hr unknown
- 2017-04-25 CY CY20171100459T patent/CY1119108T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK2841429T3 (da) | Tetrazolinonforbindelser og anvendelse deraf som pesticider | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| DK2920149T3 (da) | 3-aminocycloalkyl-forbindelser som ror-gamma-t-inhibitorer og anvendelser deraf | |
| DK3597644T3 (da) | Kationiske aminlipider og anvendelser deraf | |
| BR302013002258S1 (pt) | Configuração aplicada em frasco | |
| BR302012003235S1 (pt) | Configuração aplicada em frascos | |
| DK2809669T3 (da) | Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika | |
| BR302013000659S1 (pt) | Configuração aplicada em garrafa | |
| BR302013000658S1 (pt) | Configuração aplicada em garrafa | |
| BR302012005103S1 (pt) | Configuração aplicada em frasco | |
| BR302012005698S1 (pt) | Configuração aplicada em garrafa | |
| BR302012003569S1 (pt) | Configuração aplicada em frasco | |
| BR302012003539S1 (pt) | Configuração aplicada em frasco | |
| BR302012003654S1 (pt) | Configuração aplicada em frasco | |
| DK2880228T3 (da) | Stilladsstruktur | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| BR302012005004S1 (pt) | Configuração aplicada em garrafa | |
| DK3392252T3 (da) | Pyrimido-pyridazinonforbindelser og deres anvendelse | |
| BR302012003653S1 (pt) | Configuração aplicada em frasco | |
| DK2736888T3 (da) | 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika | |
| BR112015007217A2 (pt) | compostos e usos do composto | |
| DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf | |
| BR302013000386S1 (pt) | Configuração aplicada em frasco | |
| BR302012004808S1 (pt) | Configuração aplicada em garrafa |